At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
uterine artery embolization +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
EMMY Trial: a Randomized Comparison of Uterine Artery Embolization and Hysterectomy for the Treatment of Symptomatic Uterine Fibroids
ZonMw: The Netherlands Organisation for Health Research and Development·interventional·Posted Dec 24, 2004·Updated Jun 24, 2005
In Brief
A Phase 3 clinical trial evaluating uterine artery embolization and hysterectomy for Menorrhagia and 2 related conditions. Completed, across 2 sites.
Detailed Summary
The Emmy trial is set up to evaluate the safety and efficacy of uterine artery embolization (UAE) in comparison to hysterectomy for the treatment of symptomatic uterine fibroids. UAE was considered equivalent to hysterectomy when at least 75% of patients had normalization of heavy menstrual blood loss after treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMenorrhagia, Leiomyoma, Uterine Neoplasms
CountriesNetherlands
CollaboratorsBoston Scientific Corporation
Timeline
Phase 3CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2002
First PostedDec 2004
Study CompletionApr 2006
TodayJul 2026
First PostedDec 24, 2004
Enrollment StartFeb 1, 2002
Study CompletionApr 1, 2006
TodayJul 2, 2026
Posted 21.5 years ago
Interventions
uterine artery embolizationprocedure
hysterectomyprocedure